| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/16/2004 | EP1427451A2 Fluorescent agents for real-time measurement of organ function |
| 06/16/2004 | EP1427325A2 Management of gastro-intestinal disorders |
| 06/15/2004 | US6750323 Platelet activation protein |
| 06/15/2004 | US6750037 Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques |
| 06/15/2004 | US6749868 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 06/15/2004 | US6749859 Comprising a gel, cream, lotion, solution, emulsion, or powder comprising at least one radio-opaque agent, on the surface thereof or integrated into the glove |
| 06/15/2004 | US6749853 Combined methods and compositions for coagulation and tumor treatment |
| 06/15/2004 | US6749833 Design and planning system for improving the survival rate of injected structures |
| 06/15/2004 | US6749832 Labelled ascorbic acid derivatives |
| 06/15/2004 | CA2049921C Allergenic proteins from ragweed and uses therefor |
| 06/10/2004 | WO2004047746A2 Regulation of stearoyl-coa desaturase to treat obesity |
| 06/10/2004 | WO2004035093A3 Polymeric materials for site specific delivery to the body |
| 06/10/2004 | WO2004027385A3 Engineering of material surfaces |
| 06/10/2004 | WO2003013617A3 Conjugates of macrocyclic metal complexes with biomolecules and the utilization thereof for producing agents for use in nmr diagnosis and radiodiagnosis and radiotherapy |
| 06/10/2004 | US20040110928 Peptide conjugates for drug delivery |
| 06/10/2004 | US20040110746 Piperazinyl and diazapanyl benzamides and benzthioamides |
| 06/10/2004 | US20040110681 Generating library of peptides comprising gene expressing oligonucleotides encoding cyclic peptides with randomized coding sequences representing the non-bridging amino acids; treating neuroinflammatory, blood, and lung disorders |
| 06/10/2004 | US20040110203 Screening for a test agent that increases or induces a component of the p21 signal transduction pathway, thereby reducing the appearance or formation of wrinkles; used in fragrance or sunscreen |
| 06/10/2004 | US20040109825 Elevated temperature storage stable fluid compositions of a delayed-type hypersensitivity (DTH) inducer, e.g., 1-Chloro-2,4 Dinitrobenzene (DNCB) |
| 06/10/2004 | US20040109824 Particles for imaging cells |
| 06/10/2004 | US20040109823 Flexible and/or elastic brachytherapy seed or strand |
| 06/10/2004 | CA2691447A1 Ca ix-specific inhibitors |
| 06/09/2004 | EP1426353A1 1,3-minus;GLYCERIDE COMPOUND HAVING TWO IODOPHENYL GROUPS |
| 06/09/2004 | EP1425596A1 A method of using spectral-spatial exitation at magnetic resonance imaging |
| 06/09/2004 | EP1425306A2 Nanoparticles comprising biologically active tnf which is immobilised on the same |
| 06/09/2004 | EP1064005A4 Urokinase plasminogen activator receptor as a target for diagnosis of metastases |
| 06/09/2004 | EP1007504B1 Sterilized 5-aminolevulinic acid |
| 06/09/2004 | DE19925311B4 Mehrstufen-Verfahren zur Herstellung von gasgefüllten Mikrokapseln Multi-stage process for the production of gas-filled microcapsules |
| 06/09/2004 | CN1502625A Oligopeptide suppressor of matrix metalloprotease 2 |
| 06/08/2004 | US6748259 Optical imaging of induced signals in vivo under ambient light conditions |
| 06/08/2004 | US6747151 Azo compounds for type I phototherapy |
| 06/08/2004 | US6746663 Porphyrin compounds |
| 06/08/2004 | US6746662 Tetraaza base having spacer at each amide group and a proton exchange attached to each spacer molecule |
| 06/08/2004 | US6746661 Biocompatible component, therapeutically active component comprising a non-radioactive drug, and a radiopaque marker; seed has a size and shape suitable for passing through the bore of a 10 gauge needle |
| 06/08/2004 | CA2100256C A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion,and the use of said agents for said purpose |
| 06/08/2004 | CA2064814C Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 06/03/2004 | WO2004046171A1 Novel functional peptide nucleic acid and process for producing the same |
| 06/03/2004 | WO2004045650A1 Lymph node contrast agent |
| 06/03/2004 | WO2004045649A1 Contrast medium for representing lymph nodes |
| 06/03/2004 | WO2004045517A2 Method for the diagnosis and treatment of vascular disease |
| 06/03/2004 | WO2003094710A3 Medium for contrast enhancement use for ultrasonic, endoscopic and other medical examinations |
| 06/03/2004 | US20040106877 Method and device for determining state of skin surface |
| 06/03/2004 | US20040106683 show selectivity to the MC1 and MC4 melanocortin receptors as agonists and/or antagonists |
| 06/03/2004 | US20040106682 Novel benzylideneamino guanidines and their uses as ligands to the melnocortin receptors |
| 06/03/2004 | US20040106679 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 06/03/2004 | US20040106163 Analyzing blood glucose concentration in vivo through the skin, fluorescence resonance energy transfer, spectrum analysis, bioassay, monitoring the fluorescence spectrum emitted by reporter molecules |
| 06/03/2004 | US20040106154 In vivo screen using chemical inducers of dimerization |
| 06/03/2004 | US20040105865 Treatment and diagnosis of prostate cancer |
| 06/03/2004 | US20040105817 Identifying therapeutic compounds based on their physical-chemical properties |
| 06/03/2004 | US20040105815 By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes |
| 06/02/2004 | EP1424343A1 Peptide Conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 06/02/2004 | EP1424083A1 Diagnostic agent for pancreatic exocrine function |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423436A2 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 06/02/2004 | EP1423431A2 Antibodies to vla-1 |
| 06/02/2004 | EP1423426A1 Sut-2 and sut-3 genes, proteins and assays for inhibitors of lymphocyte adhesion |
| 06/02/2004 | EP1423415A2 Intracellular signaling molecules |
| 06/02/2004 | EP1423412A2 Homing peptides |
| 06/02/2004 | EP1423399A2 Hydroxypyridonate and hydroxypyrimidinone chelating agents |
| 06/02/2004 | EP1423152A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 06/02/2004 | EP1423151A1 Light-stabilized $i(in vivo) stain composition and method of manufacture |
| 06/02/2004 | EP1423120A1 2h-phthalazin-1-ones and methods for use thereof |
| 06/02/2004 | EP1423019A1 Process for preparing concentrate thickener compositions |
| 06/02/2004 | EP0907379B1 Bioactivated diagnostic imaging contrast agents |
| 06/02/2004 | EP0769966B1 Biotin compounds for targetting tumors and sites of infection |
| 06/02/2004 | CN1151846C Method for producing contrast agent for nuclear magnetic resonance tomography imaging |
| 06/01/2004 | US6743412 Administering to treat rheumatoid arthritis, cancer, restenosis |
| 06/01/2004 | CA2095813C Medicated syringe preparation |
| 05/27/2004 | WO2004044562A1 Method and apparatus for time resolved optical imaging of biological tissues as part of animals |
| 05/27/2004 | WO2004044557A2 Non-invasive measurement of analytes |
| 05/27/2004 | WO2004044227A2 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 05/27/2004 | WO2004044149A2 Method for suppressing immune system response to transplanted tissue or cells |
| 05/27/2004 | WO2004043513A2 Surface dissolution and/or bulk erosion controlled release compositions and devices |
| 05/27/2004 | WO2004043498A1 Method for measuring pancreatic metabolism |
| 05/27/2004 | WO2004043483A1 A method for treating spinal cord injury |
| 05/27/2004 | WO2004043357A2 Method of making, and the use of cytotoxic agents containing elemental selenium |
| 05/27/2004 | WO2003019142A9 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque |
| 05/27/2004 | WO2002092827A3 Corona-virus-like particles comprising functionally deleted genomes |
| 05/27/2004 | US20040103447 Schizophrenia-like mental disease model animal, method of constructing the same and use thereof |
| 05/27/2004 | US20040101911 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 05/27/2004 | US20040101564 Embolization |
| 05/27/2004 | US20040101479 Biopsy site marker and process and apparatus for applying it |
| 05/27/2004 | US20040101478 Determination phosphorylation of sampling; measurement, calibration |
| 05/27/2004 | US20040101477 Using metabolism phenotype profile of individual; calibration |
| 05/27/2004 | CA2505537A1 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 05/26/2004 | EP1421389A2 Neurofibrillary labels |
| 05/26/2004 | EP1421155A1 Colloidal nanocrystals with high photoluminescence quantum yields and methods of preparing the same |
| 05/26/2004 | EP1420880A2 Stabilization and terminal sterilization of phospholipid formulations |
| 05/26/2004 | EP1420831A1 Lipid constructs as therapeutic and imaging agents |
| 05/26/2004 | EP1420830A1 Ocular diagnosis of alzheimer's disease |
| 05/26/2004 | EP1420689A2 Systems and methods for targeted magnetic resonance imaging of the vascular system |
| 05/26/2004 | EP1420688A2 Macromolecular imaging agents for liver imaging |
| 05/26/2004 | EP1420681A2 Peptide-based multimeric targeted contrast agents |
| 05/26/2004 | EP1420635A1 Development of transgenic model for interventions in neurodegenerative diseases |
| 05/26/2004 | EP1322339A4 Method for early prediction of the onset of invasive cancer |
| 05/26/2004 | CN1499964A Irrigating fluid |
| 05/25/2004 | US6741881 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent |
| 05/25/2004 | US6740305 Feeding patient meal including, as breath test food additive substrate, linear acyl aminoacid peptidomimetic with radioactive or non-radioactively labeled carbon atom, detecting level of labeled carbon dioxide in breath samples |
| 05/21/2004 | WO2004042361A2 Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 05/21/2004 | WO2004042360A2 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body |